HK1139986A1 - Pharmaceutical manufacturing methods - Google Patents

Pharmaceutical manufacturing methods

Info

Publication number
HK1139986A1
HK1139986A1 HK10106579.4A HK10106579A HK1139986A1 HK 1139986 A1 HK1139986 A1 HK 1139986A1 HK 10106579 A HK10106579 A HK 10106579A HK 1139986 A1 HK1139986 A1 HK 1139986A1
Authority
HK
Hong Kong
Prior art keywords
manufacturing methods
pharmaceutical manufacturing
pharmaceutical
methods
manufacturing
Prior art date
Application number
HK10106579.4A
Other languages
English (en)
Inventor
Mark E Branum
Maralee Mcvean
Just Justesen
Eric J Tarcha
Original Assignee
Kineta Two Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kineta Two Llc filed Critical Kineta Two Llc
Publication of HK1139986A1 publication Critical patent/HK1139986A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
HK10106579.4A 2006-08-01 2010-07-07 Pharmaceutical manufacturing methods HK1139986A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83507806P 2006-08-01 2006-08-01
PCT/US2007/074846 WO2008063717A2 (en) 2006-08-01 2007-07-31 Pharmaceutical manufacturing methods

Publications (1)

Publication Number Publication Date
HK1139986A1 true HK1139986A1 (en) 2010-09-30

Family

ID=39430399

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106579.4A HK1139986A1 (en) 2006-08-01 2010-07-07 Pharmaceutical manufacturing methods

Country Status (6)

Country Link
US (2) US20080038753A1 (xx)
EP (1) EP2059589A2 (xx)
CN (2) CN103540575A (xx)
AU (1) AU2007321877B2 (xx)
HK (1) HK1139986A1 (xx)
WO (1) WO2008063717A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2406276A4 (en) * 2009-03-13 2012-12-05 Aerovance Inc METHOD OF RENATURING RECOMBINANT PROTEINS
WO2012161288A1 (en) * 2011-05-20 2012-11-29 Abbott Japan Co. Ltd. Immunoassay methods and reagents for decreasing nonspecific binding
WO2013059406A1 (en) * 2011-10-18 2013-04-25 Coherus Biosciences, Inc. Etanercept formulations stabilized with metal ions
CN102358897B (zh) * 2011-10-31 2013-02-13 北京三元基因工程有限公司 重组人寡腺苷酸合成酶-1的制备方法
WO2014138921A1 (en) * 2013-03-15 2014-09-18 Apotex Inc. Enhanced liquid formulation stability of erythropoietin alpha through purification processing
WO2014165769A1 (en) * 2013-04-05 2014-10-09 Mo Bio Laboratories, Inc. Kits and methods for isolating protein from biological and environmental samples
US10494661B2 (en) 2015-01-27 2019-12-03 Bgi Shenzhen Stabilizer for preserving biological samples
US10695395B2 (en) 2015-12-23 2020-06-30 Phoenix Tissue Repair, Inc. Collagen 7 compositions and methods of using the same
CN109852602B (zh) * 2019-01-11 2021-08-24 江南大学 一种提高酶稳定性的方法
CN109856383B (zh) * 2019-03-05 2022-04-15 肖国林 一种用于宫颈癌辅助诊断的免疫化学染色试剂盒
CN110283798B (zh) * 2019-07-09 2021-01-08 武汉华肽生物科技有限公司 一种基因重组蛋白Tat-hMsrA的纯化方法
AU2022314709A1 (en) * 2021-07-23 2024-02-22 Clara Foods Co. Purified protein compositions and methods of production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648244A (en) * 1993-09-27 1997-07-15 President And Fellows Of Harvard College Production, purification, cleavage and use of fusion peptides
CA2222696C (en) * 1995-05-31 2005-01-04 Kirin Beer Kabushiki Kaisha Virus resistant plants expressing animal cell-derived (2'-5') oligoadenylate synthetase and ribonuclease l and a method for creating the same
DE69936946T2 (de) * 1998-05-06 2008-05-15 Genentech, Inc., South San Francisco Reinigung von Antikörpern durch Ionenaustauschchromatographie
EP2267154A1 (en) * 2003-10-23 2010-12-29 Illumigen Biosciences, Inc. Oligoadenylate synthetase
UA95446C2 (xx) * 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Мутації в генах oas1$мутаци в генах oas1
EP1963497A2 (en) * 2005-11-23 2008-09-03 Illumigen Biosciences, Inc. Novel pharmaceutical compositions for the treatment of virus infection and cancer

Also Published As

Publication number Publication date
US20080038753A1 (en) 2008-02-14
CN101627117A (zh) 2010-01-13
CN101627117B (zh) 2013-10-30
AU2007321877B2 (en) 2011-11-03
WO2008063717A3 (en) 2008-10-02
EP2059589A2 (en) 2009-05-20
CN103540575A (zh) 2014-01-29
AU2007321877A1 (en) 2008-05-29
WO2008063717A2 (en) 2008-05-29
US20130157293A1 (en) 2013-06-20

Similar Documents

Publication Publication Date Title
TWI372322B (en) Manufacturing system
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
ZA200809546B (en) Pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
HK1139986A1 (en) Pharmaceutical manufacturing methods
ZA200806318B (en) Drug combinations
EP2035622A4 (en) forming section
IL197883A0 (en) Combination drug
GB0625783D0 (en) Medicament
GB0600967D0 (en) Methods
GB0613031D0 (en) Medicaments
GB0615064D0 (en) Medicament
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0713585D0 (en) Equivalent
GB0608264D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0622332D0 (en) Drug
GB0625433D0 (en) Pharmaceutical combinations
GB0614457D0 (en) Pharmaceutical Combinations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170731